CCL2 released at tumoral level contributes to the hyperalgesia evoked by intratibial inoculation of NCTC 2472 but not B16-F10 cells in mice.

MLA

Pevida, Marta, et al. “CCL2 Released at Tumoral Level Contributes to the Hyperalgesia Evoked by Intratibial Inoculation of NCTC 2472 but Not B16-F10 Cells in Mice.” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 385, no. 11, Nov. 2012, pp. 1053–61. EBSCOhost, https://doi.org/10.1007/s00210-012-0787-2.

APA

Pevida, M., González-Rodríguez, S., Lastra, A., Hidalgo, A., Menéndez, L., & Baamonde, A. (2012). CCL2 released at tumoral level contributes to the hyperalgesia evoked by intratibial inoculation of NCTC 2472 but not B16-F10 cells in mice. Naunyn-Schmiedeberg’s Archives of Pharmacology, 385(11), 1053–1061. https://doi.org/10.1007/s00210-012-0787-2

Chicago

Pevida, Marta, Sara González-Rodríguez, Ana Lastra, Agustín Hidalgo, Luis Menéndez, and Ana Baamonde. 2012. “CCL2 Released at Tumoral Level Contributes to the Hyperalgesia Evoked by Intratibial Inoculation of NCTC 2472 but Not B16-F10 Cells in Mice.” Naunyn-Schmiedeberg’s Archives of Pharmacology 385 (11): 1053–61. doi:10.1007/s00210-012-0787-2.